Literature DB >> 17975850

Problem of aspartimide formation in Fmoc-based solid-phase peptide synthesis using Dmab group to protect side chain of aspartic acid.

Jarosław Ruczyński1, Brygida Lewandowska, Piotr Mucha, Piotr Rekowski.   

Abstract

The sequence-dependent, acid- or base-catalysed aspartimide formation is one of the most serious side reactions in solid-phase synthesis of peptides containing aspartic acid. In the present work, we investigated the susceptibility of 4-(N-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]amino)benzyl (Dmab), an aspartic acid beta-carboxy side-chain protecting group, for aspartimide formation. As a model, 15-amino acid-residue galanin fragment analogue containing the Asp-Ala motif was used during Fmoc-based solid-phase synthesis. Our study showed a strong tendency of Dmab-protected peptide to form aspartimide with unusual high efficiency. Furthermore, to investigate the susceptibility of Asp-Ala motif for aspartimide formation during the synthesis using Asp(ODmab), a 5-amino acid-residue galanin fragment LGPDA, different types of resin linkers, variety of Fmoc-deprotection conditions and coupling methods were applied.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17975850     DOI: 10.1002/psc.941

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  3 in total

1.  Analysis of isoaspartic Acid by selective proteolysis with Asp-N and electron transfer dissociation mass spectrometry.

Authors:  Wenqin Ni; Shujia Dai; Barry L Karger; Zhaohui Sunny Zhou
Journal:  Anal Chem       Date:  2010-09-01       Impact factor: 6.986

2.  Selective covalent capture of collagen triple helices with a minimal protecting group strategy.

Authors:  Le Tracy Yu; Jeffrey D Hartgerink
Journal:  Chem Sci       Date:  2022-02-17       Impact factor: 9.825

3.  Prevention of aspartimide formation during peptide synthesis using cyanosulfurylides as carboxylic acid-protecting groups.

Authors:  Kevin Neumann; Jakob Farnung; Simon Baldauf; Jeffrey W Bode
Journal:  Nat Commun       Date:  2020-02-20       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.